NivoIpiliReconstruct: Approximate survival data for Nivolumab plus Ipilimumab
In nchenderson/DelayedSurvFit: Constrained Survival Estimation with Delayed Treatment
Description
Usage
Format
Details
Source
References
Examples
Description
Reconstructed survival data from a study involving
the comparison of Nivolumab plus Ipilimumab vs. chemotherapy
in the treatment of patients having advanced non–small-cell lung cancer.
Usage
1
data("NivoIpili")
Format
A data frame with 1166 observations on the following 3 variables.
timesvector of follow-up times
evntvector of event indicators
trttreatment assignment indicators; 1 - Nivolumab + Ipili, 0 - chemotherapy
Details
Approximate survival data reconstructed from survival curves extracted
from Hellmann et al. (2019)
Source
Hellmann, Matthew D., et al. (2019). "Nivolumab plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer." New England Journal of Medicine.
References
Hellmann, Matthew D., et al. (2019). "Nivolumab plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer." New England Journal of Medicine.
Examples
1
2
nchenderson/DelayedSurvFit documentation built on Jan. 21, 2021, 9:15 a.m.
R Package Documentation
Browse R Packages
We want your feedback!
Note that we can't provide technical support on individual packages. You should contact the package authors for that.
Description Usage Format Details Source References Examples
Description
Reconstructed survival data from a study involving the comparison of Nivolumab plus Ipilimumab vs. chemotherapy in the treatment of patients having advanced non–small-cell lung cancer.
Usage
1 | data("NivoIpili")
|
Format
A data frame with 1166 observations on the following 3 variables.
timesvector of follow-up times
evntvector of event indicators
trttreatment assignment indicators; 1 - Nivolumab + Ipili, 0 - chemotherapy
Details
Approximate survival data reconstructed from survival curves extracted from Hellmann et al. (2019)
Source
Hellmann, Matthew D., et al. (2019). "Nivolumab plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer." New England Journal of Medicine.
References
Hellmann, Matthew D., et al. (2019). "Nivolumab plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer." New England Journal of Medicine.
Examples
1 2 |
R Package Documentation
Browse R Packages
We want your feedback!
Note that we can't provide technical support on individual packages. You should contact the package authors for that.
Embedding an R snippet on your website
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.